About Us

Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Dubai, Mauritius and Sri Lanka with 54 healthcare facilities (including projects under development), approximately 10,000 potential beds and 314 diagnostic centres.

In a global study of the 30 most technologically advanced hospitals in the world, its flagship, the Fortis Memorial Research Institute’ (FMRI), was ranked No.2, by ‘topmastersinhealthcare.com, and placed ahead of many other outstanding medical institutions in the world.

About Us

VisionMissionValuesThe BrandMessage From Executive ChairmanBoard Of DirectorsManagement Team

Malvinder Mohan Singh

Executive Chairman, Fortis Healthcare Limited

 
 

Malvinder is a dynamic, young business leader who has made a mark on the global landscape by simultaneously pursuing the twin objectives of business for profit and for public good, in a way that positively impacts lives.

With the intent of providing broad based world class services through transformative business and delivery models, Malvinder is shaping the contours of the healthcare and financial services industries and driving their evolution.

In Healthcare, Malvinder incubated and established Fortis Healthcare Limited, in the late 1990's. Since then, he has been instrumental in transforming it into a leading healthcare delivery company in India and more recently in Asia, as the largest emerging healthcare organisation.

With a vision of making quality healthcare services accessible to all, he continues to assiduously pursue this objective, to make it a reality, using innovative business models.

In the Financial Services and Insurance sectors, Malvinder has business interests through Religare Enterprises. As Chairman of the company till 2010, he evolved Religare's strategy of creating an integrated financial services organization in India and an emerging global asset management platform.

Previously, Malvinder was Chairman, MD and CEO of Ranbaxy Laboratories. He led the expansion of Ranbaxy through a series of strategic partnerships and acquisitions resulting in Ranbaxy becoming a top 10 generic pharmaceutical company, globally. He spearheaded the coming together of Ranbaxy and Daiichi Sankyo, to create the world's fifteenth largest pharmaceutical company – a move seen as a game-changer by industry experts.

Malvinder strongly believes in the ability of people to do extraordinary things, in challenging environments. In a precedence setting move, he entrusted the management of Religare to a professional management team by stepping down as Chairman of the company in 2010. He continues to oversee his family's majority interest in Religare, as shareholder.

Malvinder has always supported strategic business decisions in the best interest of the companies he has led and continues to lead. The sale of his personal stake in Ranbaxy to Daiichi Sankyo, to secure longevity and a place for Ranbaxy as a top ranking Global Pharmaceutical Company and his decision to exit investments in Parkway Healthcare, emphatically demonstrated his ability to steer his companies, always keeping the best interests of its stakeholders, in mind.

Malvinder has a strong personal belief in the social responsibility of individuals and corporates. With a focus on affordability and accessibility to life saving medicines in emerging and under developed countries; he channelled resources towards innovation, to reduce the cost of ARV medication and for the development of a new low cost synthetic anti-malarial drug. He keenly supports initiatives to provide curative and preventive healthcare to the under privileged in India's villages and urban slums through various foundations and trusts.

Malvinder is a member of the Board of Visitors at the Fuqua School of Business (Duke University, USA) and the Board of the Indian Council for Research on International Economic Relations (ICRIER). He was a member of the first batch of the Young Global Leaders initiative of the World Economic Forum. A graduate in Economics, he earned his MBA from the Fuqua School of Business, Duke University, USA.

 

Shivinder Mohan Singh

Non Executive Vice Chairman, Fortis Healthcare Limited

 
 

Shivinder Mohan Singh is an entrepreneur who aspires to change the way Healthcare is delivered in the world. He is the Non Executive Vice Chairman of Fortis Healthcare Limited, a leading, integrated healthcare delivery provider in the Pan Asia-Pacific region. Fortis' healthcare verticals span primary healthcare, speciality day care, diagnostics and hospitals, with an asset base in 10 countries, many of which represent the fastest-growing healthcare delivery markets in the world. Fortis is driven by the vision of becoming a global leader in the integrated healthcare delivery space and the larger purpose of saving and enriching lives through clinical excellence.

Shivinder is also one of the principal promoters of Religare Enterprises Limited, Super Religare Laboratories Limited and Religare Technologies Limited. He was one of the key promoters of global pharma major Ranbaxy Laboratories and a director on its board; playing a strategic role in its sale and in taking the company to the next level, while creating significant long-term value for all stakeholders.

Shivinder has done his MBA with specialisation in health sector management from the Duke University Business School, USA. His significant contribution to Indian Healthcare is widely acknowledged. His strategy for Fortis, and its execution, has been recognised by the Harvard Business School as a case study. For over a decade, Shivinder has led from the front in shaping the private healthcare space in India. He is an alumnus of Doon School and an Honours Graduate in Mathematics from St. Stephens College, Delhi. He has lead various healthcare bodies and state level initiatives for the industry. He is also the Chairman of the Membership Committee of FICCI (Federation of Indian Chambers of Commerce and Industry).

While healthcare is a passion for Shivinder, his dream is to contribute in building a vibrant India. He is involved in a number of initiatives focused on social change - a better future for the girl child, HIV education, quality healthcare in Rural India and more. Shivinder is on the board of visitors of Fuqua School of Business, Duke University, USA and the board of trustees of Aspen India. He is also on the national board of advisors for AIESEC, a global, non-political and independent, not-for-profit organization run by students and graduates from institutions of higher education.

Shivinder lives with his wife Aditi and their four sons, in New Delhi. He likes sports such as football and tennis and enjoys watching films! .

 

Sunil Godhwani

 
 

Mr. Sunil Godhwani in his capacity as a Whole-Time Director, Religare Enterprises Limited (REL), is a guide and mentor to the various group businesses of Religare. Till recently in his executive capacity as the CEO of REL, was responsible for leading and managing all the businesses. He joined Religare in 2001 and prior to that has a rich and varied experience as an entrepreneur in his family business. During his tenure at Religare he was instrumental in transforming the platform from a mono line broking led business to a diversified and well regarded financial services group.

Born and raised in New Delhi, India, Sunil pursued his higher studies internationally. He received a B. Sc. Degree in Chemical Engineering and a M.Sc. in Industrial Engineering & Finance from Polytechnic Institute of New York.

 
 
 

Harpal Singh has wide ranging experience in the Corporate and Social sectors and has held leadership positions in the Automobile, Consumer Products and Healthcare sectors. He was Non Executive Chairman of India's largest Pharmaceutical Company, Ranbaxy and is currently the Mentor and Chairman Emeritus of Fortis Healthcare.

Whilst chairing the Impact Group, he sits on the Board of Fortis Healthcare Limited, Religare Enterprises Limited, Religare Technologies Limited, Fortis Clinical Research Limited and Super Religare Laboratories Limited. He is associated at the Board level with some of India's most renowned schools which include the Doon School, the Scindia School, the Yadavindra Public School and Salwan Schools where, he is Vice Chairman of the Trust. He is also a member of the National Round Table on School Education. He is a member of the Board of Governors of IIT, Indore as also of the NIIT University. He is a member of India-UK Round Table, India-US Strategic Dialogue and of the Public Health Foundation of India.

He is Founder Chairman Trustee of Nanhi Chhaan and Chronic Care Foundations. Nanhi Chhaan Foundation focuses around the girl child, women's empowerment, tree plantation and environment issues and secularism. Mr. Singh is Chair of INDIA800 Foundation, India Office. He is currently the Chairman of the Save the Children, India and is also a Director of the Global Board of Save the Children International.

Harpal Singh, graduated with a B.A. (Honors) degree in Economics from St. Stephen's College, Delhi and holds a B.S. degree in Economics and a Master's degree in Public Affairs from the California State University at Hayward (C.S.C.H.), California, U.S.A.

 

Dr. Brian W Tempest

 
 

Dr. Brian Tempest advises Companies, Banks, Investment Funds, Private Equity & High Net Worth Individuals on their Strategy in Asia based on his wide experience in China, Japan, South East Asia and India where he has lived for the last decade.

Brian started working for Ranbaxy Laboratories in 1995 and he held the positions of Regional Director, President, Managing Director and Chief Executive Officer until 2005 when Ranbaxy became the 9th largest Global Generic Pharmaceutical Company. He then became Chief Mentor, Vice Chairman and Non Executive Director until 2008 when he retired. He is one of the few Westerners to have led a Sensex Nifty 50 Indian blue chip MNC and as a result has a valuable insight into India. Brian has also worked for Glaxo as Regional Director-Far East and Regional Director-Middle East & Africa from 1985 to 1992.

He has worked in the Pharmaceutical Industry for the last 42 years and has managed Healthcare Businesses in North America, South America, Europe, Africa, Middle East, Australasia, China, Japan and India and has led many sessions at Investor Meetings held around the world from Tokyo to Las Vegas.

Brian is Independent Chairman of Religare Capital Markets, a Non Executive Director of SRL Diagnostics, Fortis Healthcare and Glenmark Pharmaceuticals Ltd. Brian speaks at global conferences on the structural changes in the Global Pharmaceutical Marketplace and most of his presentations in the last decade are available on www.briantempest.com.

Brian received a PhD in Chemistry from Lancaster University in 1971 and in 2009 he became Chairman of the Advisory Board for the Lancaster University Management School. He is a Fellow of the Royal Society of Chemistry and a Fellow of the Royal Society of Medicine. He is now Chairman and Senior Partner at Hale & Tempest Co Ltd in the UK.

 

Dr. P. S. Joshi

 
 

Dr. Preetinder Singh Joshi, an eminent Cardiologist, holds an MBBS degree in Medicine from Medical College, Amritsar (Punjab University, Chandigarh 1970) and MD degree in Cardiology & General Medicine from Maulana Azad Medical College (Delhi University 1974). (He stood first in the University and was declared best graduate of Medical College, Amritsar). He became a member of Royal College of Physicians, UK (MRCP) in 1978.

He is a Fellow of American College of Cardiology (FACC), Fellow Royal College of Physicians Edinburgh (FRCP) and Fellow Cardiological Society of India. He has over 40 years of experience in medical profession in India and abroad. He has held many positions of responsibility including Directorship and Head, Department of Medicine & Cardiology Divisions in Escorts Medical Centre (1981-84), Birla Centre for Medical Research, New Delhi (1984-85) & Maharaj Sawan Singh Charitable Hospital, Beas (1985-till date).

 

Joji Sekhon Gill

 
 

Joji Sekhon Gill is a HR veteran, with over 24 years of experience. Her stints in organisations spread across North America, India, Europe and Asia, have given her extensive exposure to best practices in Global Human Resources. She has recently joined DuPont as Strategic Human Resources Director.

Prior to this worked with Microsoft India for six years, as Human Resources Director-a role that made her responsible for managing doubling of the company's headcount from 3,000 to 6,000 people. Earlier, Joji has worked with Symantec, Veritas, and KLA-Tencor, USA.

Joji has a Masters degree in Personnel Management and Industrial Relations from Panjab University, Panjab, India.

 

Ms. Lynette Joy Hepburn Brown

 
 

Ms. Lyn Hepburn-Brown is an executive leader with over 30 years experience in healthcare, mergers and acquisition, private equity, education, regulatory and nursing services management across Asia Pacific.

She is a former executive manager, chief executive and board member of regulatory authorities, aged care facilities, mental health facilities, public and private hospitals, clinical services, nursing and healthcare agencies in Australia, and is presently an executive and non-executive Director for several organisations across the technology, healthcare, consulting, private equity, and memorial sectors.

She holds a Bachelor of Nursing from the University of South Australia and is a past chair of the Australian Nursing and Midwifery Council as well as a past board member of the Nurses Board of South Australia. She is an Adjunct Associate Professor to the Division of Health Sciences of the University of South Australia.

 

Pradeep Ratilal Raniga

 
 

Pradeep Ratilal Raniga has rich experience of over 29 years in the fields of accounting, taxation, legal structures, asset protection, financial planning, and financing. Currently, he also serves as a Financial Consultant to various companies in Australia, a country to which he migrated in 1985, from South Africa.

Prior to branching out independently, Pradeep was with HLB Mann Judd, Melbourne, rising to Partner and Member of the firm's Executive Committee. Before that he was a Partner at Farrar Jeena & Company, South Africa.

Pradeep has a Bachelors degree in Commerce from the University of Durban Westville, South Africa, and a Post-Graduate Diploma in Accounting from the University of Natal, South Africa. He has qualified as a Chartered Accountant in South Africa and is also a member of the Australian Institute of Chartered Accountants.

 

Mr. Ravi Mehrotra

 
 

Mr. Ravi Mehrotra has over 25 years of experience in the Financial services domain both in India and internationally. He is currently associated with Religare Group. Prior to this, Mr. Mehrotra was associated with PineBridge Investments (erstwhile AIG) where he was the Global Head of Retail & Intermediary Channels. His career span also includes assignments in India as the President of Franklin Templeton Asset Management, CIO of Kothari Pioneer, Executive Vice President & Co-founder of Prime Securities and Vice President of Bank of America in their Investment Banking & Treasury Group.

 

Ms. Shradha Suri Marwah

 
 

Ms.  Shradha Suri Marwah is a Post Graduate from The London School of Economics.
She is part of The Suri Group, which has interests in a diverse range of businesses ranging from Automotive Air-conditioner, Hospitality, Precision Component Manufacturing and Telecom to Education
She is having over 14 years of experience and she is Managing Director of Subros Limited, where she has been a critical part of Change Management and taken the company to new heights. Her key focus areas being creation of a strong R&D, HR, Quality and IT systems enabling decision support.
As a Young Entrepreneur & Visionary Leader, she also drives the Telecom Business of the group where the company (a telecom solutions provider) is engaged  in design and manufacturing of access and optical networking equipments.

 

Request an Media Interaction